AGP Executive Report
Last update: 4 hours agoPBS Cancer Breakthrough: Minjuvi (tafasitamab) has been listed on Australia’s PBS for adults with relapsed or refractory follicular lymphoma, marking a chemotherapy-free dual-target immunotherapy option. Public Health Awareness: Atrial fibrillation is being flagged as a major, often symptom-free stroke risk, with calls for more routine heart rhythm checks. Maternal Health Research: A new study suggests pregnancy loss is more common than previously thought, adding urgency to better support and understanding. Health System Watchdog: An investigation says Australia’s medical device regulator (TGA) is short-staffed to handle rising adverse event reports, raising concerns about safety oversight capacity. Workforce & Care Pressure: Doctors warn urgent care clinics aren’t relieving pressure on hospitals, leaving patients stuck in a strained system. Policy & Cost of Living: The fuel excise discount ends, with Treasurer Jim Chalmers urging the ACCC to scrutinise bowser price rises. Wellness Event: Barbara O’Neill will run a six-day wellness retreat in Egypt focused on gut health, hormones, sleep, immunity and digestion.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
